• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.

作者信息

Vogelzang N J, Bonomi P D, Rossof A H, Wolter J

出版信息

Cancer Treat Rep. 1978 Oct;62(10):1595-7.

PMID:709563
Abstract
摘要

相似文献

1
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Cancer Treat Rep. 1978 Oct;62(10):1595-7.
2
"CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
Cancer Clin Trials. 1979 Winter;2(4):321-6.
3
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.环磷酰胺、阿霉素、甲氨蝶呤和丙卡巴肼（CAMP）——用于转移性非小细胞支气管癌的有效四联化疗方案。
Cancer Treat Rep. 1976 Sep;60(9):1225-30.
4
Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Cancer Treat Rep. 1979 Aug;63(8):1351-3.
5
Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
Cancer Treat Rep. 1981 Nov-Dec;65(11-12):959-63.
6
CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
Cancer Treat Rep. 1981 Mar-Apr;65(3-4):317-20.
7
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
JAMA. 1978 Dec 15;240(25):2743-6.
8
[Antineoplastic chemotherapy for bronchial carcinoma].[支气管癌的抗肿瘤化疗]
Arch Geschwulstforsch. 1985;55(1):63-71.
9
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
Cancer Treat Rep. 1978 Mar;62(3):327-32.
10
Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.小细胞支气管癌的化疗：洛莫司汀与阿霉素联合用药与洛莫司汀、阿霉素、长春新碱及丙卡巴肼联合用药的比较
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):997-1000.

引用本文的文献

1
Comparison of survival in nonresected well differentiated and poorly differentiated adenocarcinoma of the lung.未切除的高分化和低分化肺腺癌生存率的比较。
J Cancer Res Clin Oncol. 1980;97(1):71-9. doi: 10.1007/BF00411280.
2
Combination chemotherapy (high-dose methotrexate with citrovorum factor rescue, mechlorethamine, and procarbazine) in non-small cell lung cancer.
Cancer Chemother Pharmacol. 1983;11(2):106-7. doi: 10.1007/BF00254256.
3
Chemotherapy of advanced non-small cell lung cancer. A review.晚期非小细胞肺癌的化疗。综述。
Invest New Drugs. 1984;2(3):339-47. doi: 10.1007/BF00175389.
4
Renal impairment following the combined use of high-dose methotrexate and procarbazine.
Cancer Chemother Pharmacol. 1988;21(3):265-7. doi: 10.1007/BF00262783.
5
Combination chemotherapy for advanced adenocarcinoma of the lung. A review.晚期肺癌腺癌的联合化疗。综述。
Cancer Chemother Pharmacol. 1988;21(2):103-16. doi: 10.1007/BF00257355.
6
Current options in the treatment of non-small cell lung cancer.非小细胞肺癌的当前治疗选择。
Drugs. 1992;44 Suppl 4:46-59. doi: 10.2165/00003495-199200444-00006.